FIELD: medicine.
SUBSTANCE: group of inventions refers to methods of treating urinogenital neurological disorders with using drug preparations containing a modified clostridial toxin, and using modified clostridial toxins in preparing drug preparations for treating the urinogenital neurological disorders. The methods of treating the urinogenital neurological disorders involve the stage of administering a therapeutically effective amount of a composition containing the modified clostridial toxin into a mammal in need thereof.
EFFECT: group of inventions is characterised by the effective treatment of the urinogenital neurological disorders and minimal effects in the regions being other than the goals of the toxin therapy.
15 cl, 11 dwg, 2 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INTRACELLULAR CONVERSION OF SINGLE-STRANDED PROTEINS INTO THEIR DOUBLE-STRANDED FORM | 2011 |
|
RU2569185C2 |
| DEGRADABLE CLOSTRIDIAL TOXINS | 2011 |
|
RU2561465C2 |
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| THERAPEUTIC FUSION PROTEINS | 2012 |
|
RU2651492C2 |
| SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER | 2019 |
|
RU2791640C2 |
| CATIONIC NEUROTOXINS | 2015 |
|
RU2733493C2 |
| FUSION PROTEINS AND METHODS OF TREATMENT, PREVENTION OR ALLEVIATION OF PAIN | 2013 |
|
RU2652954C2 |
| PHARMACEUTICAL COMPOSITIONS OF CLOSTRIDIA TOXIN | 2009 |
|
RU2535003C2 |
| RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM | 2006 |
|
RU2412253C2 |
| NEUROTOXINS THAT DISPLAY REDUCED BIOLOGICAL ACTIVITY | 2010 |
|
RU2582266C2 |
